The advertisement promotes VYNDAMAX as a treatment for ATTR-CM, highlighting its approval to help patients live longer and reduce heart-related issues.
Creative Information
| CID: | 6a004432-4b4a-4b7f-96fe-c838caa41848 |
| CRID: | 25_r2q3swij |
| Domain: | pfizer.com |
| Seat: | TTD |
| Size: | 300x600 |
| Bid: | $3.06 |
| Timestamp: | 12/11/2025, 3:52:40 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/11/2025, 3:59:02 PM | 6.72s | |
| adomain_analysis | success | 12/11/2025, 4:02:46 PM | 3.90s | |
| adomain_capture | success | 12/11/2025, 4:02:42 PM | 0.08s | |
| ad_render | success | 12/11/2025, 3:58:55 PM | 39.86s | |
| brand_mapping | success | 12/11/2025, 3:52:40 PM | 0.08s | |
Analysis Results
Ad Format: banner
Brands: Pfizer
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 2124.86 KB | ||||||||||||||||||||||
| Render Time: | 8.82 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 2144.07 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


